Interstitial pneumonia associated with viral replication in lung tissue was observed after cytomegalovirus infection of total-body y-irradiated mice, whereas in noncompromised hosts the lungs were not affected and virus multiplication was restricted to the salivary glands. The radiation damage could either predispose normally nonpermissive cell types for productive infection or In the therapeutic treatment of leukemia patients by irradiation and bone marrow transplantation, a major complication results from interstitial pneumonia associated with reactivation of latent herpesviruses. In most cases viral pneumonia with a very high incidence of mortality is due to cytomegalovirus (CMV), whereas pneumonia associated with herpes simplex virus or with varicella zoster is less frequent and also less severe (30).
In the therapeutic treatment of leukemia patients by irradiation and bone marrow transplantation, a major complication results from interstitial pneumonia associated with reactivation of latent herpesviruses. In most cases viral pneumonia with a very high incidence of mortality is due to cytomegalovirus (CMV), whereas pneumonia associated with herpes simplex virus or with varicella zoster is less frequent and also less severe (30) .
The experimental infection of mice with murine CMV (MCMV) has proven an appropriate model to study CMV pathogenesis since this infection of a natural host is also linked with interstitial pneumonia (5, 19, 39) . Like in the infection of humans with human CMV, immunosuppression is a prerequisite for MCMV reactivation from latency (13, 20, 29) and for infection of the lungs (5) . These findings indicate that the establishment of productive infection in the tissues of the host is not only dependent on the virulence of the virus and the presence of permissive cells but is also controlled by the immune system.
During acute intraplantar MCMV infection of immunocompetent BALB/c mice, the presence of activated interleukin (IL)-receptive cytolytic T-lymphocyte precursors (IL-CTLp) has been demonstrated in the draining popliteal lymph node (LN) by measuring the lytic potential of the IL-CTLp-derived effector CTLs after in vitro propagation mediated by IL only (34) . In this combined protocol of in vivo sensitization and in vitro propagation, Lyt-2+ CTLs are generated that are able to recognize and destroy embryonic fibroblast target cells at a stage of viral replication when only immediate-early proteins are expressed (35, 36) . It has been proposed that CTLs with such a specificity are candidates to limit viral replication in infected tissues before the production of progeny virions occurs (36) .
Adoptive transfer experiments have been applied to demonstrate the in vivo potential of immune lymphoid populations (1, 17, 24, 26, 31, 41, 45, 47) , as well as of CTL lines or clones (8, 27, 28, 38) , in various virus infections, including the infection with MCMV (17, 41) . Collectively, these studies have confirmed that mature, self-restricted Lyt-2+ CTLs can exert an antiviral effect in vivo.
Provided that CTLs are also responsible for the prevention of MCMV replication in the lungs of the immunocompetent host during persistent infection, it follows that sensitized CTLp do not require in vitro propagation to mature to antiviral effector cells. This prediction can be tested by direct adoptive transfer by using the infected immunocompetent animal as donor of activated lymphocytes and the irradiated infected animal as recipient. MATERIALS 19/178 (16) . To deplete for L3T4+ lymphocytes, mAB GK1.5 (immunoglobulin G2b) was used (10) .
To prove the efficiency of depletion of L3T4+ lymphocytes, normal splenocytes were treated either with mAB GK1.5 and complement or, for control, with complement alone. Thereafter, 5 x 106 cells per ml of minimal essential medium a were incubated for 20 h in the presence of 10 jig of the T-cell mitogenic lectin concanavalin A (Pharmacia, Uppsala, Sweden). Minimal essential medium a without nucleosides (GIBCO Laboratories, Grand Island, N.Y.) was supplemented with 5% fetal calf serum, 2 mM L-glutamine, and 5 x 10-5 M 2-mercaptoethanol. The IL-2 content of the culture supernatant was then assessed with a nonhelper subline (21) of the IL-2-dependent BALB/c-derived T-cell line HT-2 (44) and was found to be 10% of the control value.
Bone marrow cell populations obtained by flushing medium through the shafts of the femori and tibiae of normal BALB/c mice were depleted for cells of the T-cell lineage by using a mixture of the mABs anti-Lyt-2.2 and GK1. 5 (3) and processed for hybridization by published procedures (4). The hybridization solution (15) IlI (11, 22) tritiated by nick translation (37) to a specific activity of 4 x 107 dpm/,g. After hybridization at 37°C for 24 h the specimens were washed at 37°C for 5 min three times in 50% formamide-3x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and for 60 min three times in 3 x SSC, dehydrated, coated for autoradiography with NTB 3 photoemulsion (Eastman Kodak Co., Rochester, N.Y.) and exposed for 3 days at 4°C. Coincidence of mortality and increase in lung tissue virus titers. Forty 10-week-old female BALB/c mice were subjected at day zero to y irradiation with a single dose of 6 Gy (equal to a lethal dose causing 50%o of the mice to die within 30 days), followed by intraplantar infection with 105 PFU of MCMV. Thereafter, two groups were formed by distributing the mice randomly. The kinetics of virus multiplication in the lungs was measured in one group (the mean titer of two random samples is depicted), and the incidence of death was monitored in the second group (the bars represent numbers of deceased animals for each day). In infected but not irradiated controls 0 of 20 mice died, whereas in irradiated but not infected controls 11 of 20 mice died within the observation period of 30 days. The arrowheads mark the virus titers at day 6 and day 14, which are important for the subsequent experimental schedules.
RESULTS
Effect of -y irradiation on the tissue manifestation of infection. In immunocompetent donors, footpad infection elicited a marked cellular immune response in the draining popliteal LN, as indicated by an increase in cell numbers from 106 to 2 x 107 within 8 days and a frequency of activated MCMVspecific CTLp in the order of lo-3 to 1i-' depending on the in vitro propagation protocol applied (34) . When 105 PFU of cell culture-grown MCMV was used for infection, no signs of inflammation were detectable at the site of infection, nor could infectious virus be recovered at day 14 p.i. from organs such as lungs, spleen, or liver, although infectious virus was recovered from the salivary glands, which are a privileged site for MCMV replication during persistency (Fig. 1) . Accordingly, MCMV, formerly named salivary gland virus of the mouse, has originally been isolated from persistently infected salivary glands (40) .
On the contrary, in 6-Gy fy-irradiated recipients, immunosuppression was manifested by a decline in the cell numbers of the popliteal LN from 106 to 104 within 8 days and the absence of activated MCMV-specific CTLp after infection (data not shown). In the footpad, a highly exudative process with extensive hemorrhages and local necrosis was seen histologically at day 14 p.i. (F. Weiland, manuscript in preparation), and high virus titers were observed not only in the salivary glands but also in liver, spleen, and lungs ( Fig. 1) .
Evidence for interstitial pneumonia. To establish a model for viral pneumonia, it had to be verified that virus detected in the lungs of the immunosuppressed host is autochtonously replicating in lung tissue and is not just disseminated from the salivary glands. Histological studies demonstrated symptoms of a moderate focal interstitial pneumonia: cell swelling, exudation of fluid into interstitial areas, and cells located in the widened alveolar septa containing intranuclear inclusions (Fig. 2a) . The etiology of this infection was confirmed by in situ hybridization (Fig. 2b) by using plasmid cloned MCMV DNA fragments (11, 22) . With this highly specific and sensitive technique, infected cells could be detected in lung tissue at day 6 p.i., and thereby it was proved that infection was established at that time (Fig. 2c) . Electron microscopic analysis identified interstitial cells (Fig. 2d) , pneumocytes, and endothelial cells (data not shown) as the target cells for MCMV replication in lung tissue after irradiation when cellular infiltration was virtually absent. After immunosuppression of mice by treatment with antilymphocyte antiserum, MCMV has been shown to replicate also in pulmonary macrophages (5) .
The dying of the irradiated, infected animals coincided with a log-linear increase in tissue virus titers, as exemplified for the lungs (Fig. 3) . The virus titer observed in the liver ( Fig. 1 and 4 ) was due to infection of hepatocytes causing focal necrosis (data not shown), and in addition other essential organs may be affected.
Prophylactic adoptive transfer of specifically activated lymphocytes. This type of transfer protocol was applied for probing the capacity of in vivo-sensitized lymphocytes to prevent the tissue manifestation of the MCMV infection. The lymphocytes were taken from the draining popliteal LN of immunocompetent donors (BALB/c mice, H-2d haplotype) infected in the footpad 8 days previously and were transferred intravenously into irradiated syngeneic recipients that were infected in the footpad 2 h after cell transfer. The read-out time for the virus titers in the organs was defined as 14 days p.i. at the peak of mortality in the nonreconstituted control group (Fig. 3) . From the results depicted in Fig. 4 Fig. 1 and 4) , and accordingly all recipients survived.
Clinical trials in the therapy of leukemia involve reconstitution with type-matched bone marrow after totalbody or total-lymphoid irradiation (30) Therapeutic adoptive transfer of specifically activated lymphocytes. The therapeutic adoptive transfer is a means to investigate the question of whether activated lymphocytes can limit viral replication in the lungs even during established infection of the tissue. MCMV-infected cells were detectable in the lungs at day 6 p.i. (Fig. 2c) 20 producing cells in the lungs. Interference with viral replication at such a germinal stage of lung tissue infection should retard the log-linear increase in virus titers. Accordingly, transfers were performed at day 6 p.i., and as was the case for the prophylactic transfer, the virus titers were determined at day 14 p.i. (Fig. 5) . Under these conditions, syngeneic bone marrow transplantation was again inefficient with respect to the control of lung tissue infection (P > 0.1; compare columns B and C), whereas transfer of 106 activated lymphocytes (column D) confined the increase in virus titers (significant [P = 0.005]) to <5% of the positive control values (columns B, C, and E), resulting in an absolute difference in virus load of >105 PFU. This antiviral effect was evidently mediated by lymphocytes sensitized in the infected donors, since transfer of the same amount of resting lymphocytes derived from popliteal LN of nonimmune donors was not effective (P = 0.1; compare columns B and E).
Absence of specific antibody in transfer recipients. was monitored by an enzyme-linked immunosorbent assay at day 8 posttransfer. There was no indication of a role for sensitized B lymphocytes at the early stages of reconstitution, since MCMV-specific antibody could not be detected in the recipients, whereas latently infected mice, inoculated with MCMV as newborns, proved to be seropositive (data not shown). Serological characterization of cells that limit viral replication in the lungs. Before therapeutic adoptive transfer into irradiated and infected recipients, the activated donor lymphocytes were preselected for distinct subsets by complement-dependent cytolysis with mABs to the cell surface antigens Lyt-2.2, preferentially expressed by class I major histocompatibility complex antigen-restricted T lymphocytes (42), or L3T4, specific for most class II major histocompatibility complex antigen-restricted T lymphocytes (10, 33) (Fig. 6 ). These markers appear not to be coexpressed on mature T lymphocytes (10, 33) , whereas both are present on immature thymocytes (9, 10) . Treatment with mAB GK1.5, specific for the L3T4a determinant (10), did not significantly affect the ability of the population to limit viral replication (P > 0.1; compare columns B and D), whereas in a control experiment the lectin-induced production of IL-2 by splenocytes was reduced to 10%, indicating that IL-2-producing helper T lymphocytes can be eliminated by the protocol applied (data not shown; for details see above). On the other hand, depletion of the transferred population for Lyt-2+ lymphocytes, predominantly representing CTL and their precursors, abrogated the antiviral effect in lung tissue (significant [ (8, 27, 28) . In herpes simplex virus infection, the antiviral effect of transferred acutely sensitized lymphocyte populations has been assigned to the Lyt-1+2-subset (24) . Besides cloned Lyt-1-2+ CTLs, cloned Lyt-1+2+ CTLs have been shown to be active in allogeneic tumor rejection (12) , and a role of Lyt-1+2+ lymphocytes in the control of viral infection has also been suggested (43 (14, 46) .
Evidence in favor of direct in vivo cytolysis has been presented recently for influenza A virus infection (28) , and arguments against direct in vivo cytolysis have been discussed for infection with lymphocytic choriomeningitis virus (26) . Our data do not disfavor either of these theories. According to a recent report, the spread of established pulmonary sarcoma metastases could be inhibited only when high numbers of in vitro lymphokine-activated killer cells and high doses of recombinant IL-2 were administered in combination (32) . Compared with this tumor model, the established pulmonary MCMV infection appears to be more accessible to immune surveillance since significant interference with viral replication was achieved with comparatively low numbers of in vivo-sensitized Lyt-2+, L3T4-T lymphocytes without in vitro restimulation and without application of IL-2. Experiments are in progress to test whether the therapeutic effect of transferred MCMV-specific lymphocytes can be enhanced by IL-2.
CMV specify a multitude of polypeptides, and it would be of interest to know against which viral or virus-induced antigens the cellular immune response is directed. It has been shown that MCMV replication stage-specific CTLs can be distinguished that recognize target cells carrying viral structural proteins or expressing a lymphocyte-detected immediate-early antigen (35) . Although only one major immediate-early protein is synthesized in infected cells (23) , a high number of activated CTLp present in the draining LN after infection were found to be specific for lymphocytedetected immediate-early antigen (36) , suggesting that this antigen is immunodominant.
Virus replication in the lungs of irradiated hosts after therapeutic transfer of CTL lines or clones specific for lymphocyte-detected immediate-early antigen or other antigens specified by MCMV provides a relevant parameter to test the functional competence of CTLs with different specificities and to evaluate the implication of particular antigens in immune surveillance during acute, persistent, and latent CMV infection.
